Cas 866939-13-1,1,1-dimethylethyl 7-[(5-chloro-2-pyrazinyl)oxy]-1,2,4,5-tetrahydro-3H-3-benzazepine-3-carboxylate

866939-13-1

Post Buying Request

Basic information

Product Name: 1,1-dimethylethyl 7-[(5-chloro-2-pyrazinyl)oxy]-1,2,4,5-tetrahydro-3H-3-benzazepine-3-carboxylate
Synonyms: 1,1-dimethylethyl 7-[(5-chloro-2-pyrazinyl)oxy]-1,2,4,5-tetrahydro-3H-3-benzazepine-3-carboxylate
CAS NO:866939-13-1
Molecular Formula:
Molecular Weight: 375.855
EINECS: N/A
Product Categories: N/A
Mol File: 866939-13-1.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1,1-dimethylethyl 7-[(5-chloro-2-pyrazinyl)oxy]-1,2,4,5-tetrahydro-3H-3-benzazepine-3-carboxylate(CAS DataBase Reference)
NIST Chemistry Reference: 1,1-dimethylethyl 7-[(5-chloro-2-pyrazinyl)oxy]-1,2,4,5-tetrahydro-3H-3-benzazepine-3-carboxylate(866939-13-1)
EPA Substance Registry System: 1,1-dimethylethyl 7-[(5-chloro-2-pyrazinyl)oxy]-1,2,4,5-tetrahydro-3H-3-benzazepine-3-carboxylate(866939-13-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 866939-13-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

866939-13-1 Suppliers

Recommended suppliersmore

866939-13-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 866939-13-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,6,9,3 and 9 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 866939-13:
(8*8)+(7*6)+(6*6)+(5*9)+(4*3)+(3*9)+(2*1)+(1*3)=231
231 % 10 = 1
So 866939-13-1 is a valid CAS Registry Number.

866939-13-1Upstream product

866939-13-1Downstream Products

866939-13-1Relevant articles and documents

TERTRAHYDROBENZAZEPINES AS HISTAMINE H3 RECEPTOR LIGANDS

-

Page/Page column 15, (2010/02/14)

The present invention relates to novel benzazepine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 866939-13-1